A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients

被引：55
作者：
Alvarez, RD
Curiel, DT
机构：
[1] Division of Gynecologic Oncology, Old Hillman Building, Birmingham, AL 35233-7333
[2] Gene Therapy Program, Wallace Tumor Institute, Birmingham, AL 35233-7333
来源：
HUMAN GENE THERAPY | 1997年 / 8卷 / 05期
关键词：
RETROVIRAL VECTOR; BRAIN-TUMORS; CELLS; THERAPY; CHEMOTHERAPY;
D O I：
10.1089/hum.1997.8.5-597
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：597 / 613
页数：17
相关论文
共 25 条
[11]  
Freeman SM, 1992, J CELL BIOCH F, V16F, P47
[12]  
FRIEDMANN T, 1992, CANCER, V70, P1810, DOI 10.1002/1097-0142(19920915)70:4+<1810::AID-CNCR2820701624>3.0.CO
[13]  
2-3
[14]   INHIBITION BY ACYCLOVIR OF CELL-GROWTH AND DNA-SYNTHESIS OF CELLS BIOCHEMICALLY TRANSFORMED WITH HERPESVIRUS GENETIC INFORMATION [J].
FURMAN, PA ;
MCGUIRT, PV ;
KELLER, PM ;
FYFE, JA ;
ELION, GB .
VIROLOGY, 1980, 102 (02) :420-430
[15]  
JENKINS J, 1982, SURG GYNECOL OBSTET, V154, P858
[16]  
KARP JE, 1994, CANCER RES, V54, P653
[17]   GENE-THERAPY - ADENOVIRUS VECTORS [J].
KOZARSKY, KF ;
WILSON, JM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1993, 3 (03) :499-503
[18]   A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase ganciclovir system for the treatment of refractory or recurrent ovarian cancer [J].
Link, CJ ;
Moorman, D ;
Seregina, T ;
Levy, JP ;
Schabold, KJ .
HUMAN GENE THERAPY, 1996, 7 (09) :1161-1179
[19]  
RAM Z, 1993, CANCER RES, V53, P83
[20]   GENE-THERAPY FOR CANCER [J].
SIKORA, K .
TRENDS IN BIOTECHNOLOGY, 1993, 11 (05) :197-201
123